Posts

Showing posts with the label Antisense Oligonucleotides Market

Top Ten Common Prejudices About Polyethylene Naphthalate Market.

Image
In 2014, the global polyethylene naphthalate market was worth USD 827.0 million, and it is expected to grow at a CAGR of 7.5 percent over the next five years. Because of its improved thermal and barrier properties, such as oxidation resistance, polyethylene naphthalate (PEN) is primarily used in packaging applications. Over the forecast period, rising demand for high-strength photographic films is likely to drive market expansion. polyethylene naphthalate market Because of their higher stiffness modulus, PEN films are a major component of food packaging applications, providing increased barrier properties and enhancing the material's strength. These films are also used to make pressure sensitive tapes and thermal sheets. They are also involved in the protection of solar cells. Forward integration of raw material providers in PEN manufacturing is a feature of the polyethylene naphthalate market. These businesses actively consume raw materials in order to create their products. Con...

Ten Doubts You Should Clarify About Antisense Oligonucleotides Market.

Image
Antisense Oligonucleotides Market are single-stranded RNA or DNA molecules with a short length. Antisense oligonucleotides do not affect the activity of already generated proteins; rather, they act at the level of messenger RNA in the cell before proteins are made. Antisense oligonucleotides are employed in the therapy of cancer, CNS therapeutics, inflammatory therapeutics, diabetes, asthma, hair loss, and other diseases. In genomics, antisense oligonucleotides are also employed. Antisense nucleotides include fomivirsen, which is used to treat cytomegalovirus retinitis, and mipomersen, which is used to treat high cholesterol. The rising number of launches pertaining to novel Antisense Oligonucleotides Market products by key players in the industry is one of the primary reasons driving growth of the global antisense oligonucleotides market. Exiqon A/S, which was bought by Qiagen in 2015, released novel LNA Antisense Oligonucleotide GapmeRs in 2015. In functional analysis, the LNA Anti...